To study the temporal alteration of Gankyrin expression during hepatocarcinogenesis, liver samples at successive stages of HCC development, including normal liver, chronic hepatitis, cirrhosis, AH, and HCC tissues, were immunohistochemically stained using an anti-Gankyrin antibody. Here, PSMD10 is linked to hepatocellular carcinoma.